#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14738	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2223	660.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1524	1524	C	896	C	845	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14738	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2223	660.3	0	HET	.	.	.	A198G	.	198	198	A	538	538	A	865	A,G	595,187	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26564	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3627	730.4	0	.	n	.	0	T695C	SNP	695	695	T	1066	1066	C	808	C,T	745,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26564	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3627	730.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	2009	2009	G	857	G,A	813,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26564	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3627	730.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2342	2342	C	825	C	771	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26564	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3627	730.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2416	2416	A	847	A	801	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26564	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3627	730.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2968	2968	C	831	C,T	603,178	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2022	folP	855	855	100.0	folP.l15.c4.ctg.1	1416	141.5	1	SNP	p	R229S	1	.	.	685	687	AGC	950	952	AGC	233;232;233	A;G;C,T	214;213;213,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4682	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3294	141.6	1	SNP	p	S91F	1	.	.	271	273	TTC	528	530	TTC	165;166;164	T;T;C	155;155;153	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4682	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3294	141.6	1	SNP	p	D95G	1	.	.	283	285	GGC	540	542	GGC	161;159;158	G;G;C	150;148;147	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4682	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3294	141.6	1	SNP	p	G95N	0	.	.	283	285	GGC	540	542	GGC	161;159;158	G;G;C	150;148;147	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1666	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1502	110.5	1	SNP	p	G45D	0	.	.	133	135	GGC	482	484	GGC	197;195;195	G;G;C	189;186;186	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	798	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1034	76.5	0	.	n	.	0	A197.	DEL	197	197	A	545	545	A	210	A	191	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5078	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2929	172.5	1	SNP	p	D86N	0	.	.	256	258	GAC	478	480	GAC	220;220;221	G;A;C	206;198;206	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5078	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2929	172.5	1	SNP	p	R87I	0	.	.	259	261	CGT	481	483	CGT	223;224;225	C,T;G;T	208,1;207;207	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5078	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2929	172.5	1	SNP	p	S87R	1	.	.	259	261	CGT	481	483	CGT	223;224;225	C,T;G;T	208,1;207;207	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5078	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2929	172.5	1	SNP	p	R87W	0	.	.	259	261	CGT	481	483	CGT	223;224;225	C,T;G;T	208,1;207;207	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5078	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2929	172.5	1	SNP	p	S88P	0	.	.	262	264	TCC	484	486	TCC	224;224;219	T;C;C	205;204;201	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4244	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2817	150.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1646	1648	GGC	194;191;187	G;G;C	174;174;170	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1263	1265	GCC	208;208;207	G;C;C	193;194;192	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1266	1268	ATG	205;206;206	A;T;G	191;193;192	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1278	1280	ACC	207;206;205	A,T;C;C,G	192,1;192;190,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1278	1280	ACC	207;206;205	A,T;C;C,G	192,1;192;190,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1779	1781	ACC	203;207;208	A;C,T;C	184;191,1;194	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1833	1835	GCG	203;203;205	G;C;G	191;192;193	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1833	1835	GCG	203;203;205	G;C;G	191;192;193	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1956	1958	GGT	164;163;162	G;G;T	148;150;146	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1965	1967	AGC	159;156;157	A;G;C	147;144;144	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4034	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2504	160.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1983	1985	CCG	132;131;130	C,G;C,G;G	93,10;94,2;94	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5642	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	2963	189.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1615	1617	CCG	192;194;195	C;C;G	174;178;175	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2220	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1750	125.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	540	540	C	161	C	150	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	A251V	NONSYN	751	753	GCG	69	71	GTA	31;31;31	G;T;A	28;27;28	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	S271T	NONSYN	811	813	TCG	129	131	ACT	52;49;45	A;C;T	43;44;40	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	135	137	GAT	37;36;33	G;A;T	32;31;31	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	D276N	NONSYN	826	828	GAT	144	146	AAC	33;33;33	A;A;C	31;30;30	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	N277H	NONSYN	829	831	AAC	147	149	CAC	33;32;32	C;A;C	30;31;31	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	R307E	NONSYN	919	921	AGA	237	239	GAA	8;8;8	G;A;A	8;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	249	251	GCA	10;10;10	G;C;A	10;10;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	252	254	GAC	10;10;10	G;A;C	10;10;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	258	260	ATC	9;8;8	A;T;C	9;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	264	266	TCG	8;9;8	T;C;G	7;9;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	270	272	GCC	9;9;9	G;C;C	9;9;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	273	275	AGC	9;9;9	A;G;C	8;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	276	278	GCC	8;8;8	G;C;C	8;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	248	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	371	21.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	282	284	GTT	8;8;8	G;T;T	8;8;8	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2734	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1628	167.1	1	SNP	p	G120K	1	.	.	358	360	AAG	689	691	AAG	235;237;239	A;A;G	215;218;213	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2734	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1628	167.1	1	SNP	p	A121N	1	.	.	361	363	AAC	692	694	AAC	238;234;230	A;A;C	218;212;210	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2734	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1628	167.1	1	SNP	p	N121D	0	.	.	361	363	AAC	692	694	AAC	238;234;230	A;A;C	218;212;210	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10000	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4867	204.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1072	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1020	104.5	1	SNP	p	V57M	1	.	.	169	171	ATG	504	506	ATG	239;238;238	A;T;G	224;224;225	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
